Richard A. Larson

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

The antioxidants of higher plants

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia